|  | Collecting Quality Data in Psychiatric Trials Understanding interactions among the many factors that give rise to mental illness is a complex task. Learn how to identify and mitigate these elements early on to help ensure trial data accurately captures your compound’s safety and efficacy potential. Premier Research. Built for BiotechSM |
Today's Rundown Featured Story | | | Tuesday, March 24, 2020 With $80 million upfront and up to $1.6 billion in biobucks, Astellas is still ramping up the biotech deals after ending 2019 on a buyout high. |
|
|---|
|
|  | Metabolon reveals a new ally for drug research and development programs. Learn more. |
Top Stories Tuesday, March 24, 2020 Novavax’s influenza vaccine NanoFlu has outperformed Sanofi’s Fluzone Quadrivalent on measures of immunogenicity in a phase 3 trial. The trial hit its primary and key secondary endpoints, sending Novavax’s stock up 40% and sparking talk of an accelerated FDA approval. Monday, March 23, 2020 As confirmed COVID-19 cases in New York blow past 20,000, the state is teaming up with a pharma partner to test a plasma-based treatment in critically ill patients, Forbes reported Monday. The clinical trial will test transfusions of blood plasma with antibodies against the novel coronavirus taken from patients who have survived COVID-19 infection. Tuesday, March 24, 2020 Urovant Sciences has snagged itself a new CEO as it preps for the potential launch of its overactive bladder treatment: Jim Robinson, the former chief operating officer of Paragon Biosciences and Alkermes. Robinson takes over from Keith Katkin, who has led Urovant since September 2017. Tuesday, March 24, 2020 The U.K. government has backed a University of Oxford effort to develop a vaccine against COVID-19. Officials handed out the cash to help Sarah Gilbert’s team deliver on its plans to get a vaccine against the novel coronavirus into clinical testing next month. Monday, March 23, 2020 A technology invented by Penn researchers and being developed by Carisma Therapeutics attaches CARs to macrophages, immune cells that are naturally drawn to solid tumors and equipped to survive in a hostile tumor environment. The CAR-M technology has shown promise in mouse models of ovarian cancer, the researchers reported, and Carisma is planning a phase 1 human trial. Monday, March 23, 2020 Since its coronavirus diagnostic received the first emergency green light from the FDA 10 days ago, Roche has delivered over 400,000 kits to laboratories across the U.S.—but CEO Severin Schwan said it could take weeks or even months for the industry as a whole to catch up to the widespread need for testing. Enrollment Showcase | | | Presented by: Global EMBA for Healthcare & the Life Sciences, University of Toronto Prepare to step up in your career, build the expertise you need to reshape your organization, and explore opportunities worldwide. |
|
|---|
|
Resources Sponsored by: Outer Edge Technology To survive in these challenging conditions, companies need to promptly address business continuity issues - especially the remote delivery of data and voice solutions. See how Outer Edge can help. Sponsored by: Patheon, by Thermo Fisher Scientific Poorly soluble molecules hindering your workflow? Sponsored by: eClinical Solutions Key findings from the 2019 Life Sciences Data & Analytics Survey conducted by the Tufts Center for the Study of Drug Development will be unveiled during this live webinar led by industry expert and study lead, Ken Getz, Director of Sponsored Programs and Associate Professor. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Outer Edge Technology See why innovative BioPharma’s are partnering with Cloud Service Provider’s to design, manage and implement cloud strategies to smooth the path to FDA approval and enhance their competitive prowess. Sponsored by: Metabolon Metabolomics can help you streamline your drug development process by providing the framework to make a stronger, more confident, and more valuable case for a molecule in a shorter timeframe. Sponsored by: Epsilon Download this e-book to learn 9 ways to enhance the customer experience within healthcare marketing. Sponsored by: Reprints Desk/Research Solutions 3 ways you may be overspending on scientific literature access, and how to fix them. Sponsored by: Baxter When different drug products are produced in shared facilities, potential for cross-contamination needs to be addressed. Outsourcing to a CMO with experience in multiproduct facilities can be an option. Sponsored by: WCG Metrics Champion Consortium Ineffective measurement could mean wasting both time and money. This whitepaper showcases a custom-built Metric Maturity Model that helps illustrate and define the process for measuring the right things the right way. Sponsored by: The Kinetix Group Read about the innovative ways payers are making smart moves in the healthcare game. Sponsored by: Catalent This whitepaper discusses the benefits of end-to-end solutions and share case studies on how flexible manufacturing strategies can accommodate the changing landscape of pharmaceutical products and help bring a drug to market. Sponsored by: Catalent Get expert insights on strategies to implement flexible manufacturing and different technologies that are easily scalable and reproducible. Sponsored by: Catalent Regardless of the assigned FDA expedited approval designation and approach, the key action items should be: the assurance of a detail-oriented plan and the adaption of a “forward-thinking” approach that will assist in any future challenges and opportunities for growth of each project. | 
